Biolog, Inc. Awarded National Institutes of Health (NIH) Grant To Develop Antimicrobial Database Using Phenotype MicroArray Technology Platform
10/19/2005 5:12:52 PM
HAYWARD, Calif.--(BUSINESS WIRE)--March 1, 2005--Biolog, Inc. announced today that it has been awarded a phase I SBIR grant from the National Institutes of Health NIAID Biodefense Program. The grant will be to develop the Phenotype MicroArray(TM) (PM) technology as a tool in antimicrobial development. It will fund the application of Biolog's innovative PM technology as a tool for evaluation of biologically active compounds using Staphylococcus aureus as the model organism. This application will be added to the expanding application capabilities of PM technology for research in bacteria, yeast, and filamentous fungi.